Adjuvant treatment in resected biliary cancers: fluoropyrimidines on the spotlight

Transl Cancer Res. 2024 Sep 30;13(9):4510-4513. doi: 10.21037/tcr-24-1007. Epub 2024 Sep 27.

Authors

Pedro Luiz Serrano Uson Junior^{1

2

3}, Mitesh J Borad¹

Affiliations

¹ Division of Hematology/Oncology, Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ, USA.
² Division of Hematology/Oncology, Hospital do Coração, HCOR, Sao Paulo, Brazil.
³ Center for Personalized Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

No abstract available

Keywords: Capecitabine; S1; biliary tract cancer (BTC); fluoropyrimidines.

Publication types

Editorial
Comment